BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31101763)

  • 21. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.
    Wei F; Yang L; Jiang D; Pan M; Tang G; Huang M; Zhang J
    Cancer Med; 2020 Apr; 9(7):2480-2490. PubMed ID: 32022476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo.
    Sun X; Zheng G; Li C; Liu C
    Mol Med Rep; 2019 Jan; 19(1):685-692. PubMed ID: 30431133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
    Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
    Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
    Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
    Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
    Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
    Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma.
    Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C
    Exp Mol Pathol; 2021 Jun; 120():104638. PubMed ID: 33878313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
    Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
    Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MEG2 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting AKT pathway.
    Ying D; Ruan Y; Zhou X
    Gene; 2019 Mar; 687():1-8. PubMed ID: 30399427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Zhangyuan G; Wang F; Zhang H; Jiang R; Tao X; Yu D; Jin K; Yu W; Liu Y; Yin Y; Shen J; Xu Q; Zhang W; Sun B
    Oncogene; 2020 Feb; 39(6):1213-1230. PubMed ID: 31605014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
    Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
    BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA.
    Yao J; Hua X; Shi J; Hu X; Lui K; He K; Mai J; Lan T; Lu M
    FASEB J; 2022 Apr; 36(4):e22238. PubMed ID: 35224785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis.
    Li C; Miao R; Liu S; Wan Y; Zhang S; Deng Y; Bi J; Qu K; Zhang J; Liu C
    Oncotarget; 2017 Apr; 8(17):28683-28695. PubMed ID: 28404923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.
    Tang J; Zhuo H; Zhang X; Jiang R; Ji J; Deng L; Qian X; Zhang F; Sun B
    Cell Death Dis; 2014 Dec; 5(12):e1549. PubMed ID: 25476897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway.
    Yin YZ; Zheng WH; Zhang X; Chen YH; Tuo YH
    J Cell Biochem; 2020 Jan; 121(1):735-742. PubMed ID: 31478228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.